Veeva provides software, data, and business consulting for research and development, quality, and commercial operations in the life sciences industry.

Veeva

ProGamma Science Corporation is a multidisciplinary company that provides comprehensive and economic solutions for technical operations and compliance in the pharmaceutical, biopharmaceutical, Natural Health Products, and medical devices industries. Self-described as offering high quality for client projects.

PROGAMMA SCIENCE

Adgistics provides a Digital Asset Management platform designed to help manage marketing content effectively.

Adgistics

OneStudyTeam builds solutions that connect and empower the clinical trial ecosystem, offering a cloud-based platform, StudyTeam, that simplifies site workflows while providing sponsors with visibility into recruitment and enrollment progress.

OneStudyTeam

Generation Veeva

Veeva Consumer Products

Veeva Systems APAC

Veeva MedTech

Veeva Crossix

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 875 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Canada, Europe, Asia, and Latin America. Visit the Jobs section for open positions and remember that correspondence to new applicants and existing candidates will only come from an official @veeva.com email address. 

Emergence

Veeva Systems

Targeted investment in non-promotional medical activities–such as congresses, publications, guidelines, clinical trials, and social media activity–prior to launch significantly accelerates treatment adoption.

However, some activities have more of an impact than others.

Read the full report: https://bit.ly/3LGOQxw

#medicalaffairs #veevapulse #pharma #medaffairs

Out today! New Veeva Pulse data reveals targeted pre-launch scientific outreach maximizes medical affairs teams’ impact on treatment adoption. Find how and learn more: https://lnkd.in/ggVpv2pM

#veevapulse #pharmaceuticals #lifesciences

For the first time in the industry, a Commercial Content Taxonomy for Life Sciences is being released, built from an in-depth analysis of 475+ configurations within Vault PromoMats. 

This global taxonomy is now publicly available to enhance content management efficiency and support industry-specific content technologies, including AI solutions.

The Commercial Content Taxonomy brings long-term benefits by:

✅ Preventing innovation from being hindered by customization
✅ Easing integrations
✅ Enhancing the end-user experience
✅ Making it simpler and more cost-effective 

Watch the video and download the Taxonomy here: https://bit.ly/4d7pQLw


#pharmaceuticals #contentstrategy

Ever wondered about the impact of non-promotional scientific activities on treatment adoption?

Curious which of the congresses, publications, guidelines, clinical trials, or social media activity is the biggest driver?

Answers to these and more in the new Veeva Pulse Field Trends Report: https://bit.ly/4bWrEpt

In the #manufacturing lab, bringing together test execution and sample management, improving right-first-time, and allowing review by exception can deliver access to key lab data faster. Veeva’s Jason Boyd explains how and why in Pharmaceutical Technology. https://lnkd.in/gRm4gX4S 

#qualitycontrol #qualityassurance

Metric
Company Name	Veeva	PROGAMMA SCIENCE	Adgistics	OneStudyTeam
Symbol
MSH ID	COM:VEEVA	CA:PROGAMMA	COM:ADGISTICS	COM:ONESTUDYTEAM
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Technology	Healthcare & Health Services
Industry	Healthcare Technology	Pharmaceuticals & Biopharmaceuticals	Marketing Technology	Clinical Research
Country	US	CA	GB	US
Stage	Venture Round
Employee Count	8.59K
Website	veeva.com	progamma.ca	adgistics.com	onestudyteam.com
LinkedIn	veeva-systems	progamma
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	561.80K	524	6.81K
Web Traffic Growth	0.04	13.16	-0.06
Valuation
Raised Capital	4M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:VEEVA

Veeva

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue